Literature DB >> 31279840

Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review.

Chao Wang1, Dong Li2, Fengying Cai3, Xinjie Zhang1, Xiaowei Xu1, Xiaojun Liu6, Chunhua Zhang5, Dan Wang4, Xiaojun Liu6, Shuxiang Lin1, Yuqin Zhang7, Jianbo Shu8.   

Abstract

Cobalamin (cbl) C disease is a rare autosomal recessive inheritance disease, which is the most common cobalamin metabolic disorder. Its clinical phenotype involves multiple systems with varying degrees of severity, where in mild cases can be asymptomatic for many years, whereas severe cases may cause death during the neonatal period. The disease is caused by mutations in the MMACHC gene located on chromosome 1p34.1 that contains 5 exons; among which, exons 1-4 have an 849 bp coding sequence that encodes a protein containing 282 amino acids. Through clinical physical examination and laboratory tests, especially blood and urine screening, we found 28 cblC pediatric patients with clinical manifestations, such as mental retardation, motor development delay, epilepsy, metabolic acidosis, vomiting and diarrhea. By Sanger sequencing, we found homozygous or compound heterozygous mutations of MMACHC in 27 of the patients, and single heterozygous mutation of MMACHC in one of them. The c.609G > A, c.658-660delAAG, c.80A > G and c.482G > A mutations accounted for 43.64% (24/55), 10.91% (6/55), 9.09% (5/55) and 7.27% (4/55) of all the mutations, respectively. This spectrum finding is basically consistent with the previously reported data in Chinese patients. The most common c.609G > A mutation may likely lead to early-onset cblC disease. In previous literature involving a large sample of Caucasian cblC cases, the mutation spectrum of MMACHC gene is almost completely different from that of the Chinese population. The most common mutations in the Caucasian population were c.271dupA, c.394C > T and c.331C > T, which account for 48.05% (542/1128), 13.65% (154/1128) and 7.36% (83/1128) of all the mutant alleles, respectively. The c.271dupA mutation and c.331C > T mutation were mainly associated with early-onset cblC in children less than 1 year old, whilst the c.394C > T mutation was mainly associated with late-onset cblC patients characterised by isolated acute nervous system abnormalities. We also analysed the cause behind the different mutation spectrum of MMACHC gene between the Chinese and Caucasian populations.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Caucasian; Child; Chinese; MMACHC gene; Mutation spectrum; cblC disease

Mesh:

Substances:

Year:  2019        PMID: 31279840     DOI: 10.1016/j.ejmg.2019.103713

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  Clinical features and outcomes of patients with cblC type methylmalonic acidemia carrying gene c.609G>A mutation.

Authors:  Yue Yu; Shiying Ling; Ruixue Shuai; Wenjuan Qiu; Huiwen Zhang; Lili Liang; Wenjun Ji; Yuchao Liu; Xuefan Gu; Lianshu Han
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

Review 2.  Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C disease.

Authors:  Anna J Esser; Srijan Mukherjee; Ilia A Dereven'kov; Sergei V Makarov; Donald W Jacobsen; Ute Spiekerkoetter; Luciana Hannibal
Journal:  iScience       Date:  2022-08-18

3.  Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis.

Authors:  Narae Hwang; Ja-Hyun Jang; Eun-Hae Cho; Rihwa Choi; Suk-Joo Choi; Hyung-Doo Park
Journal:  Mol Genet Genomic Med       Date:  2021-10-16       Impact factor: 2.183

4.  Acute Lymphoblastic Leukemia in Combined Methylmalonic Acidemia and Homocysteinemia (cblC Type): A Case Report and Literature Review.

Authors:  Jun Zhu; Shuisen Wan; Xueqi Zhao; Binlu Zhu; Yuan Lv; Hongkun Jiang
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

5.  Rare cause of coronary artery ectasia in children: A case report of methylmalonic acidemia with hyperhomocysteinemia.

Authors:  Tu Juan; Chen Chao-Ying; Li Hua-Rong; Wan Ling
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

6.  Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment.

Authors:  Zhehui Chen; Hui Dong; Yao Zhang; Yanling Yang; Yupeng Liu; Ruxuan He; Jinqing Song; Ying Jin; Mengqiu Li; Yi Liu; Xueqin Liu; Hui Yan; Jianguang Qi; Fang Wang; Huijie Xiao; Hong Zheng; Lulu Kang; Dongxiao Li
Journal:  Orphanet J Rare Dis       Date:  2022-09-02       Impact factor: 4.303

7.  Rapid screening of MMACHC gene mutations by high-resolution melting curve analysis.

Authors:  Chao Wang; Yang Liu; Fengying Cai; Xinjie Zhang; Xiaowei Xu; Yani Li; Qianqian Zou; Jie Zheng; Yuqin Zhang; Wei Guo; Chunquan Cai; Jianbo Shu
Journal:  Mol Genet Genomic Med       Date:  2020-03-21       Impact factor: 2.183

8.  Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.

Authors:  Ruxuan He; Ruo Mo; Ming Shen; Lulu Kang; Jinqing Song; Yi Liu; Zhehui Chen; Hongwu Zhang; Hongxin Yao; Yupeng Liu; Yao Zhang; Hui Dong; Ying Jin; Mengqiu Li; Jiong Qin; Hong Zheng; Yongxing Chen; Dongxiao Li; Haiyan Wei; Xiyuan Li; Huifeng Zhang; Min Huang; Chunyan Zhang; Yuwu Jiang; Desheng Liang; Yaping Tian; Yanling Yang
Journal:  Orphanet J Rare Dis       Date:  2020-08-03       Impact factor: 4.123

9.  Noninvasive Prenatal Testing of Methylmalonic Acidemia cblC Type Using the cSMART Assay for MMACHC Gene Mutations.

Authors:  Weigang Lv; Lili Liang; Xin Chen; Zhuo Li; Desheng Liang; Huimin Zhu; Yanling Teng; Weijuan Wu; Lingqian Wu; Lianshu Han
Journal:  Front Genet       Date:  2022-01-07       Impact factor: 4.599

Review 10.  Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists.

Authors:  Silvia Kalantari; Brigida Brezzi; Valeria Bracciamà; Antonella Barreca; Paolo Nozza; Tiziana Vaisitti; Antonio Amoroso; Silvia Deaglio; Marco Manganaro; Francesco Porta; Marco Spada
Journal:  Orphanet J Rare Dis       Date:  2022-02-02       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.